The FDA's Pediatric Advisory Committee voted almost unanimously that cough medicines with opioids such as codeine and hydrocodone had greater health risks than benefits and shouldn't be given to youths younger than 18. Some doctors on the panel said there is a lack of evidence that the treatments work to suppress cough, but they can have serious side effects.

Related Summaries